Insights into obesity and insulin resistance from the study of extreme human phenotypes

European Journal of Endocrinology

Volumn 147, Issue 4, 2002, Pages 435-441

  O'Rahilly, Stephen ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FURIN; INSULIN RECEPTOR; LEPTIN; LEPTIN RECEPTOR; MELANOCORTIN 4 RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROOPIOMELANOCORTIN; RECOMBINANT LEPTIN;

AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; ENDOCRINE DISEASE; ENZYME DEFICIENCY; GENE MUTATION; GENETIC ANALYSIS; HORMONE DEFICIENCY; HUMAN; INSULIN RESISTANCE; LIPODYSTROPHY; MORBID OBESITY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

EID: 0036772389     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1470435     Document Type: Review

References (36)

1. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. New England Journal of Medicine 1994 331 1056-1061.
2. Woods KA, Camacho-Hubner C, Savage MO & Clark AJ. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. New England Journal of Medicine 1996 335 1363-1367.
3. Lifton RP, Gharavi AG & Geller DS. Molecular mechanisms of human hypertension. Cell 2001 104 545-556.
4. Stewart PM, Corrie JE, Shackleton CH & Edwards CR. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle. Journal of Clinical Investigation 1988 82 340-349.
5. Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ et al. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature 1996 384 458-460.
6. O'Rahilly S, Gray H, Humphreys PJ, Krook A, Polonsky KS, White A et al. Impaired processing of prohormones associated with abnormalities of glucose homeostasis and adrenal function. New England Journal of Medicine 1995 333 1386-1390.
7. Jackson RS, Creemers JWM, Ohagi SJC, Raffin-Sanson ML, Sanders L, Montague CT et al. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 (PC1) gene. Nature Genetics 1997 16 303-306.
8. Seidah NG & Chretien M. Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides. Brain Research 1999 848 45-62.
9. Leiter EH. Carboxypeptidase E and obesity in the mouse. Journal of Endocrinology 1997 155 211-214.
10. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994 372 425-432.
11. Friedman JM. Leptin, leptin receptors and the control of body weight. European Journal of Medical Research 1997 2 7-13.
12. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997 387 903-908.
13. Rau H, Reaves B, O'Rahilly S & Whitehead JP. Truncated human leptin (Δ133) associated with extreme obesity undergoes proteasomal degradation following defective intracellular transport. Endocrinology 1999 140 1718-1723.
14. Strobel A, Issad T, Camoin L, Ozata M & Strosberg AD. A leptin missense mutation associated with hypogonadism and morbid obesity. Nature Genetics 1998 18 213-215.
15. Farooqi S, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. New England Journal of Medicine 1999 341 879-884.
16. Farooqi IS, Keogh J, Kamath S, Jones S, Gibson WT, Trussel R et al. Partial leptin deficiency increases adiposity in humans. Nature 2001 414 34-35.
17. Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, Horvath TL et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 2001 411 480-484.
18. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997 88 131-141.
19. Yeo G, Farooqi IS, Aminian S, Halsall D, Stanhope R & O'Rahilly S. A frameshift mutation in MC4R. associated with dominantly inherited human obesity. Nature Genetics 1998 20 111-112.
20. Vaisse C, Clement K, Guy-Grand B & Froguel P. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nature Genetics 1998 20 113-114.
21. Farooqi IS, Yeo GS, Keogh JM, Aminian S, Jebb SA, Butler G et al. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. Journal of Clinical Investigation 2000 106 271-279.
22. Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B & Froguel P. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. Journal of Clinical Investigation 2000 106 253-262.
23. Sina M, Hinney A, Ziegler A, Neupert T, Mayer H, Siegfried W et al. Phenotypes in three pedigrees with autosomal dominant obesity caused by haploinsufficiency mutations in the melanocortin-4 receptor gene. American Journal of Human Genetics 1999 65 1501-1507.
24. Moller DE & O'Rahilly S. Severe insulin resistance: clinical and pathophysiological features. In Insulin Resistance, pp 50-81. Ed. DE Moller. New York: John Wiley, 1993.
25. Krook A, Brueton L & O'Rahilly S. Homozygous nonsense mutation in the insulin receptor gene in infant with leprechaunism. Lancet 1993 342 277-278.
26. Krook A, Bell JA, Robertson ME, Brueton L & O'Rahilly S. Prenatal analysis of the insulin receptor gene in a family with leprechaunism. Prenatal Diagnosis 1995 15 669-671.
27. Krook A, Moller DE, Dib K & O'Rahilly S. Two naturally-occurring mutant receptors phosphorylate insulin receptor substrate-1 (IRS-1) but fail to mediate the biological effects of insulin. Journal of Biological Chemistry 1996 271 7134-7140.
28. Krook A, Whitehead JP, Dobson SP, Griffiths MR, Ouwens M, Baker C et al. Two naturally occurring mutations in the insulin receptor tyrosine kinase domain provide evidence that PI3-kinase activation alone is insufficient for the mediation of the metabolic effects of insulin. Journal of Biological Chemistry 1997 272 30208-30214.
29. Dib K, Whitehead J, Humphreys PJ, Soos MA, Baynes KC, Kumar S et al. Impaired activation of PI3-kinase by insulin in fibroblasts from patients with severe insulin resistance and pseudo-acromegaly: a disorder characterised by selective post-receptor insulin resistance. Journal of Clinical Investigation 1998 101 1111-1120.
30. Shackleton S, Lloyd DJ, Jackson SN, Evans R, Nirmeijer NT, Singh BM et al. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nature Genetics 2000 24 153-156.
31. Magre J, Delepin M, Khallouf E, Gedde-Dahl T Jr, Van Maldergem L, Sobel E et al. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13-linked congenital generalized lipodystrophy. Nature Genetics 2001 28 365-370.
32. Barroso I, Gurnell M, Crowley VE, Agostini M, Schwabe JW, Soos MA et al. Dominant-negative mutations in human PPARγ are associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 1999 402 880-883.
33. Collingwood TN, Adams M, Tone Y & Chatterjee VK. Spectrum of transcriptional, dimerization and dominant negative properties of twenty different mutant thyroid hormone beta-receptors in thyroid hormone resistance syndrome. Molecular Endocrinology 1994 8 1262-1277.
34. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Wilson TM & Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPARgamma). Journal of Biological Chemistry 1995 270 12953-12956.
35. Savage DB, Agostini M, Barroso I, Gurnell M, Luan JA, Meirhaeghe A et al. Digenic Inheritance of severe insulin resistance in a human pedigree. Nature Genetics 2002 31 379-384.
36. Suzuki Y, Lanner C, Kim JH, Vilardo PG, Zhang H, Yang J et al. Insulin control of glycogen metabolism in knockout mice lacking the muscle-specific protein phosphatase PP1G/RGL. Molecular and Cellular Biology 2001 21 2683-2694.